Recommendations for Molecular Testing in Non-Small Cell Lung Cancer (NSCLC)
October 5th 2022A panel of lung cancer experts provides an overview of molecular testing in early-stage non-small cell lung cancer (NSCLC) and recommendations for biomarkers to test for and at what treatment stages to perform testing.
Read More
Dr. Wistuba on Maximizing Outcomes With Limited Tissue in Lung Cancer
October 11th 2016Ignacio I. Wistuba, MD, chair, Department of Translational Molecular Pathology, Division of Pathology/Lab Medicine, Anderson Clinical Faculty Chair for Cancer Treatment and Research, The University of Texas MD Anderson Cancer Center, discusses how pathologists maximize outcomes with limited tissue in patients with lung cancer.
Read More